Henry T. Lynch

Medicine · Health Sciences

123h-index79.7kcitations1.2kworks0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genetic factors in colorectal cancer(486), BRCA gene mutations in cancer(402), Cancer Genomics and Diagnostics(185), Colorectal Cancer Screening and Detection(156), DNA Repair Mechanisms(96)

Publications1.2k total

Penguin diet from space: Links between sea ice, Antarctic food webs, and population change
2025Open Access
Gene and pathway based burden analyses in familial lymphoid cancer cases: Rare variants in immune pathway genes
PLoS ONE·2023· 4 citedOpen Access
Supplementary Table 1 from Rare Mutations in <i>RINT1</i> Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
2023Open Access
Supplementary Table 3 from Rare Mutations in <i>RINT1</i> Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
2023Open Access
Data from Altered Gene Expression in Morphologically Normal Epithelial Cells from Heterozygous Carriers of <i>BRCA1</i> or <i>BRCA2</i> Mutations
2023Open Access
Supplementary Methods, Tables 1-3, Figure 1 from Altered Gene Expression in Morphologically Normal Epithelial Cells from Heterozygous Carriers of <i>BRCA1</i> or <i>BRCA2</i> Mutations
2023Open Access
Supplementary Methods, Tables 1-3, Figure 1 from Altered Gene Expression in Morphologically Normal Epithelial Cells from Heterozygous Carriers of <i>BRCA1</i> or <i>BRCA2</i> Mutations
2023Open Access
Supplementary Figure Legend from Prospective Multicenter Randomized Intermediate Biomarker Study of Oral Contraceptive versus Depo-Provera for Prevention of Endometrial Cancer in Women with Lynch Syndrome
2023Open Access
Data from Rare Mutations in <i>RINT1</i> Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
2023Open Access
Data from Making Sense of Missense in Lynch Syndrome: The Clinical Perspective
2023Open Access
Related Article from Making Sense of Missense in Lynch Syndrome: The Clinical Perspective
2023Open Access
Supplementary Table 3 from Rare Mutations in <i>RINT1</i> Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
2023Open Access
Supplementary Figure 1 from Prospective Multicenter Randomized Intermediate Biomarker Study of Oral Contraceptive versus Depo-Provera for Prevention of Endometrial Cancer in Women with Lynch Syndrome
2023Open Access
Data from Rare Mutations in <i>RINT1</i> Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
2023Open Access
Related Article from Making Sense of Missense in Lynch Syndrome: The Clinical Perspective
2023Open Access
Supplementary Table 1 from Rare Mutations in <i>RINT1</i> Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
2023Open Access
Supplementary Table 1 from Prospective Multicenter Randomized Intermediate Biomarker Study of Oral Contraceptive versus Depo-Provera for Prevention of Endometrial Cancer in Women with Lynch Syndrome
2023Open Access
Commentary on This Article from Prospective Multicenter Randomized Intermediate Biomarker Study of Oral Contraceptive versus Depo-Provera for Prevention of Endometrial Cancer in Women with Lynch Syndrome
2023Open Access
Supplementary Figure 1 from Prospective Multicenter Randomized Intermediate Biomarker Study of Oral Contraceptive versus Depo-Provera for Prevention of Endometrial Cancer in Women with Lynch Syndrome
2023Open Access
Supplementary Figure 1 from Rare Mutations in <i>RINT1</i> Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
2023Open Access
page 1 of 58Next →

Frequent Co-authors

Patrice Watson(13), Steven A. Narod(10), Susan L. Neuhausen(9), D. Gareth Evans(7), Jukka‐Pekka Mecklin(6), Claudine Isaacs(6), Olufunmilayo I. Olopade(6), Parviz Ghadirian(6), Albert de la Chapelle(5), Hans F. A. Vasen(5), Timothy R. Rebbeck(5), Judy E. Garber(5), Ellen Matloff(5), Jan Lubiński(5), William D. Foulkes(5), Ping Sun(5), Rosalind A. Eeles(4), Stanley R. Hamilton(4), Jeremy R. Jass(4), Païvi Peltomäki(4)